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SUMMARY – Th e aim of the study was to determine the prevalence of neuropathic pain in knee 
osteoarthritis patients using painDETECT questionnaire, and to evaluate correlations between pain 
intensity, gender, age and types of treatment, and the presence of neuropathic pain. Th e study included 
122 patients. All participants completed a questionnaire on sociodemographic data, duration of symp-
toms, types of treatment and preventable risk factors (body mass index and waist circumference). Th e 
presence of neuropathic pain was assessed by painDETECT, according to which subjects were classi-
fi ed into three groups (neuropathic pain likely, possible, or unlikely). Neuropathic pain was likely in 18 
(14.8%), possible in 30 (24.6%) and unlikely in 74 (60.7%) subjects. A signifi cant positive correlation 
was found between visual analog scale for pain and painDETECT score. Th ere was no statistically 
signifi cant diff erence in gender, age, waist circumference and body mass index among three groups of 
participants according to painDETECT score. In conclusion, knee osteoarthritis patients with neuro-
pathic pain component were experiencing higher levels of pain, implicating poorer pain control with 
common analgesics. Recognizing these patients as a distinct subgroup would allow clinicians to im-
prove their treatment by using unconventional analgesics with central activity.
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Introduction
As one of the most common chronic musculoskel-
etal disorders, osteoarthritis (OA) is the leading cause 
of chronic disability in developed countries. Epidemi-
ological studies estimate that about 15% of the world 
population is aff ected1. Th e incidence of OA is rapidly 
increasing and the disease is becoming a considerable 
public health burden in terms of lost working days, 
early retirement and signifi cantly increased healthcare 
costs2.
Osteoarthritis is characterized by degenerative and 
infl ammatory processes aff ecting mostly weight-bear-
ing joints (hips, knees and ankles) and surrounding tis-
sues, but any synovial joint can be aff ected1,3.
Pain is the most prominent clinical feature of OA 
and the main reason for physician offi  ce visits. Th e 
pathophysiology of pain in OA includes both nocicep-
tive and neuropathic mechanisms. Abnormal excit-
ability in pain pathways of peripheral and central ner-
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vous system corresponding to central sensitization has 
been demonstrated in OA2-4. Th e key pathological 
hallmark of OA is abnormal articular cartilage, which 
is avascular and aneural, and so cannot generate pain 
directly3. Other articular and periarticular structures 
aff ected by the disease, such as synovial membrane, 
joint capsule, subchondral bone, periosteum, periar-
ticular ligaments and muscles, are all richly innervated 
and represent the source of nociceptive pain2. Al-
though the pain in OA has generally been classifi ed as 
nociceptive (infl ammatory), the component of neuro-
pathic pain (NP) has been increasingly recognized in 
some patients3,5. Presumably, local damage to periph-
eral nerve fi bers in articular and periarticular struc-
tures, in the course of disease, leads to activation of 
neuropathogenetic mechanisms3.
Clinically, early stage of OA is characterized by 
joint pain triggered by specifi c activities and relieved 
by rest6. Later, as the disease progresses, the pain often 
becomes constant7. A proportion of OA patients use 
descriptors characteristic of NP such as burning, 
numbness, ‘pins and needles’ to address their painful 
sensations. Also, mood changes, sleep disturbance and 
fatigue, which all are manifestations of chronic pain 
states, occur more frequently in OA patients3,4.
Th e goals of OA treatment are pain control, im-
provement of function and quality of life3. Currently 
available treatments provide only modest relief of pain 
at best. Th e eff ectiveness of some fi rst-line agents, such 
as paracetamol, is hard to distinguish from placebo, 
and the eff ectiveness of nonsteroidal anti-infl ammato-
ry drugs (NSAIDs) and opioids is considered small to 
moderate4. A subgroup of OA patients, with poorly 
controlled pain by common analgesics (e.g., NSAIDs), 
has been shown to respond well to unconventional an-
algesics including tricyclic antidepressants, serotonin-
norepinephrine reuptake inhibitors or gabapentinoids8.
Th e rationale for this study was based on observa-
tions that some of the knee OA patients with chronic 
pain experience both nociceptive pain and unrecog-
nized NP. Presumably, these patients would tend to 
take higher doses of NSAIDs and report higher inten-
sities of pain.
Th e aim of this cross-sectional study was to deter-
mine the prevalence of NP in knee OA patients using 
painDETECT questionnaire, and to evaluate the cor-
relations between pain intensity, gender, age and types 
of treatment, and the presence of NP.
Patients and Methods
Study subjects were selected from outpatients diag-
nosed with knee OA attending the Division of Physi-
cal Medicine and Rehabilitation with Rheumatology, 
Dubrava University Hospital. Th ese 122 patients were 
selected from 135 knee OA patients according to the 
following inclusion criteria: history of knee pain of at 
least 12 months and diagnosis of knee OA based on 
the American College of Rheumatology (ACR) clas-
sifi cation criteria9. Exclusion criteria were a history of 
knee surgery, knee infection and rheumatoid arthritis.
All participants completed a self-administered 
questionnaire designed for this study, which included 
sociodemographic data (age and gender), duration of 
knee symptoms, types of treatment, and preventable 
risk factors (body mass index (BMI) and waist circum-
ference). Th e presence of NP component was assessed 
by painDETECT questionnaire.
Th e study protocol was approved by Ethics Com-
mittee of Dubrava University Hospital and Institu-
tional Review Board of Zagreb University School of 
Medicine. Informed consent was obtained from each 
participant.
Pain scores
Various screening tools have been developed to 
identify NP, including LANSS, DN4, NPQ, pain-
DETECT, and ID Pain5. We chose painDETECT to 
determine the presence of NP in knee OA patients 
because it does not require clinical examination, and 
shows a slightly higher sensitivity and specifi city (85% 
and 80%, respectively) in comparison to other validat-
ed questionnaires for assessment of NP5.
PainDETECT is a patient-based questionnaire 
consisting of nine items, i.e. seven weighted sensory 
descriptors and two items related to radiating and 
temporal characteristics of individual’s pain pattern. 
Th e overall score ranges from 0 to 38. A score ≥19 in-
dicates that NP is likely, a score 13-18 indicates that 
the presence of NP component is possible, and a score 
≤12 indicates that NP is unlikely. PainDETECT also 
includes visual analog scales (VAS) for pain referring 
to 3 diff erent time points (pain at entry point, most 
severe pain in the past 4 weeks, and average pain in the 
past 4 weeks), but these items do not count towards 
the overall score.
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Statistical analysis
Data are presented in tables including absolute fre-
quencies and their proportions, and arithmetic means 
with corresponding standard deviations. Kolmogorov-
Smirnov test was applied to check for normality of 
data distribution, and according to the results obtained, 
the appropriate parametric tests were used. Diff erenc-
es in age, gender, BMI, waist circumference, VAS of 
pain at entry point, most severe pain in 4 weeks and 
average pain in 4 weeks among three groups of pa-
tients according to painDETECT score (neuropathic 
pain likely, possible, or unlikely) were analyzed by one-
way ANOVA and Bonferroni post-hoc tests. Th e χ2-
test was used to analyze diff erences in categorical vari-
ables (treatment modalities), while correlations of 
VAS, gender, age, BMI, waist circumference and pain-
DETECT score were evaluated by Pearson correlation 
coeffi  cients. All p values <0.05 were considered signifi -
cant. Th e STATISTICA 10.0 (www.statsoft.com) 
software was used on analysis.
Results
Th e study included 122 participants (86 female and 
36 male), mean age 64.6 years. All subjects had a his-
tory of knee OA of at least 12 months. Th e mean VAS 
of pain at entry point was 4.37 (SD 1.98, min 0.5, max 
9.0); the mean VAS of the most severe pain during the 
last 4 weeks was 6.87 (SD 2.14, min 1.5, max 10.0); 
and the mean VAS of average pain during the last 4 
weeks was 4.99 (SD 1.83, min 1.2, max 10.0).
According to painDETECT score, NP was likely 
(score ≥19) in 18 (14.8%), possible (score ≥13 to ≤18) 
in 30 (24.6%), and unlikely (score ≤12) in 74 (60.7%) 
subjects.
Th e most frequent pattern of pain in subjects with 
unlikely NP was “Pain attacks without pain between 
them”, while subjects with possible and likely NP most 
frequently had the “Pain attacks with pain between 
them” pattern (Table 1).
A signifi cantly higher proportion of participants 
with likely and possible NP (36/48, 75%) reported ra-
diation of knee pain to other parts of leg than partici-
pants with unlikely NP (17/74, 22.97%) (p<0.001, 
χ2=0.001). Th ere was no signifi cant diff erence in gen-
der among subjects with likely, unlikely and possible 
NP (χ2=0.715).
All subjects with likely NP and 96.7% of subjects 
with possible NP were taking systemic NSAIDs com-
pared to 73% of subjects with unlikely NP, which was 
statistically signifi cant (χ2=0.002, p<0.01). Also, a 
 signifi cantly higher proportion of subjects with likely 
NP (83.3%) were treated with topical NSAIDs than 
subjects with possible and unlikely NP (53.3% and 
50%, respectively; χ2=0.037, p<0.05). None of the 
 participants was treated with opioid analgesics other 
than tramadol. Th ere was no signifi cant diff erence in 
other treatment modalities among the three groups 
(Table 2).
We found a signifi cant positive correlation between 
VAS of pain at entry point and painDETECT score 
(pc=0.43, p<0.001), VAS of most severe pain in 4 
weeks and painDETECT score (pc=0.43, p<0.001), 
and VAS of average pain in 4 weeks and painDE-
TECT score (pc=0.43, p<0.001). We also found a 
positive correlation between waist circumference and 
painDETECT score, which was not statistically sig-




TotalPersistent pain with 
slight fl uctuations
Persistent pain with 
pain attacks
Pain attacks without 
pain between them
Pain attacks with 
pain between them
0-12
n 18 20 25 11 74
% 24.3 27 33.8 14.9 100
13-18
n 1 7 10 12 30
% 3.3 23.3 33.3 40 100
19-38
n 1 1 3 13 18
% 5.6 5.6 16.7 72.2 100
Total
n 20 28 38 36 122
% 16.4 23 31.1 29.5 100
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nifi cant (pc=0.01, p=0.95), as well as negative correla-
tion between age and BMI, and painDETECT score, 
which was not statistically signifi cant either (pc=-0.03, 
p=0.74; pc=-0.08 and p=0.36, respectively).
Discussion
Like nearly all other chronic pain states, OA is 
likely a ‘mixed pain state’, with individual variability in 
the relative balance of peripheral and central elements 
of pain10. OA-related pain is presumably the result of a 
complex interaction between local tissue damage, and 
infl ammation, peripheral and central nervous system2. 
Infl ammation in the joint triggers a cascade of events, 
resulting in peripheral sensitization, increased sensi-
tivity of nociceptive primary aff erent neurons, and hy-
perexcitability of nociceptive neurons in the central 
nervous system. Peripheral sensitization is thought to 
play an important role in the development and main-
tenance of central sensitization; intense, repeated or 
prolonged input from peripheral nociceptors modu-
lates spinal cord pain-transmitting neurons and leads 
to decreased activation thresholds, increased synaptic 
excitability, and increased fi ring thresholds3. Th e pres-
ence of central sensitization is associated with a poor 
treatment outcome8.
Th is cross-sectional study showed that a signifi cant 
proportion of OA patients manifested features of NP. 
Several other studies estimated the prevalence of NP 
in patients with OA using painDETECT score at 5%-
50%5,8. More recently, Ohtori et al. found that 5.4% of 
subjects with knee OA had likely NP and 15.2% had 
possible NP5. Th is study included 92 participants with 
the mean age of 70.4 years. In our study, the propor-
tion of subjects with likely and possible NP was higher 
(14.8% and 24.6%, respectively), and the mean age of 
122 participants was lower, 64.4 years. Age has been 
recognized as the most prominent risk factor for the 
initiation and progression of OA, and the incidence of 
OA is higher in the elderly population, which can be 
explained by the cumulative eff ect of mechanical load 
resulting in ‘wear and tear’ of the joints11. Although we 
found a tendency of negative correlation between age 
and painDETECT score, implicating a higher likeli-
hood of the presence of NP component in younger 
patients with knee OA, it was not statistically signifi -
cant, and additional studies with larger samples are 
needed.
Besides the relatively small number of patients, an-
other potential limitation of this study was that reli-
ability of painDETECT for NP in knee OA had not 
been fully evaluated, and this needs to be assessed in 
further studies.
We also want to point out that despite treatment 
with analgesics and physical therapy, the level of pain 
in our subjects remained relatively high, as measured 
by VAS. Indeed, in a signifi cant proportion of OA pa-
tients, pain is still inadequately controlled with com-
Table 2. Types of treatment in three groups of patients according to painDETECT score
Type of treatment
Patient groups according to painDETECT score
0-12 13-18 19-38
n % n % n %
Laser therapy 4 5.4 2 6.7 1 5.6 0.09
Magnetotherapy 62 83.8 24 80 17 94.4 0.529
Electrotherapy 19 25.7 12 40 9 50 0.398
Th ermotherapy 3 4.1 2 6.7 0 0 0.968
Ultrasound therapy 4 5.4 1 3.3 1 5,6 0.898
Gymnastic exercises 10 13.5 6 20 6 33.3 0.139
Systemic NSAIDs 54 73 29 96.7 18 100 0.002
Topical NSAIDs 37 50 16 53.3 15 83.3 0.037
Paracetamol or paracetamol 
+ tramadol
14 18.9 5 17.2 6 33.3 0.349
Other opioid analgesics 0 0 0 0 0 0 -
NSAIDs = nonsteroidal anti-infl ammatory drugs
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mon analgesics, which leads to disability and impaired 
quality of life4.
Our results further indicated that knee OA pa-
tients with likely and possible NP experienced higher 
levels of pain and were more likely to take NSAIDs 
(both systemic and topical) than patients without NP 
component, implicating poorer pain control. A sub-
group of OA patients with NP component, who may 
benefi t from treatment with centrally acting analgesics 
such as opioids, antiepileptics, tricyclic antidepres-
sants, and serotonin/norepinephrine receptor inibi-
tors8, mostly remain unrecognized. Implementation of 
a simple NP questionnaire in routine clinical practice 
would contribute to early recognition and appropriate 
treatment of these patients.
Conclusion
According to the painDETECT questionnaire, 
14.8% of our participants likely had NP component, 
and another 24.6% possibly had it. Th ese patients were 
experiencing higher levels of pain, implicating poorer 
pain control with common analgesics. Recognizing 
these patients as a distinct subgroup would allow clini-
cians to improve their treatment by using non-stan-
dard analgesics with central activity.
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Sažetak
POKLANJAMO LI DOVOLJNO POZORNOSTI NEUROPATSKOJ BOLI 
U BOLESNIKA S OSTEOARTRITISOM KOLJENA?
M. Golob, I. Marković, N. Zovko, D. Šakić, A. Gudelj-Gračanin i J. Morović-Vergles
Cilj ovoga rada bio je odrediti učestalost neuropatske boli u bolesnika oboljelih od osteoartritisa koljena primjenom 
upitnika painDETECT te istražiti povezanost prisustva neuropatske boli s intenzitetom boli, spolom i dobi bolesnika te 
modalitetom liječenja. U istraživanje je bilo uključeno ukupno 122 bolesnika. Svi ispitanici ispunili su upitnik koji je uključi-
vao sociodemografske podatke, podatke o indeksu tjelesne mase i opsegu struka. Prikupljani su i podaci o trajanju simptoma 
i modalitetima liječenja. Prema podacima dobivenim pomoću upitnika painDETECT bolesnici su svrstani u tri skupine: one 
koji imaju prisutnu komponentu neuropatske boli, one koji je možda imaju i one kod kojih ona nije prisutna. Rezultati su 
pokazali da je komponenta neuropatske boli prisutna kod 18 ispitanika, moguća kod njih 30, dok 74 ispitanika nije imalo 
elemenata koji bi govorili u prilog postojanju neuropatske boli. Rezultat upitnika painDETECT značajno je korelirao s 
 vizualno analognom ljestvicom boli. Istraživanjem nismo dokazali statistički značajnu povezanost dobi, spola, opsega struka 
i indeksa tjelesne mase s prisustvom neuropatske boli. Bolesnici s osteoartritisom koljena koji imaju prisutnu komponentu 
neuropatske boli trpe bol koju ne ublažavaju standardni analgetici. Prepoznavanje te skupine bolesnika među oboljelima 
omogućilo bi njihovo uspješnije liječenje nestandardnim analgeticima centralnog djelovanja.
Ključne riječi: Osteoartritis, koljeno; Bol, liječenje; Neuralgija; Analgetici; Ankete i upitnici; Rizični čimbenici
